These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18763068)
41. Construction of recombinant adeno-associated virus vector containing the rat preproinsulin II gene. Peng L; Sidner RA; Bochan MR; Burton MM; Cooper ST; Jindal RM J Surg Res; 1997 Apr; 69(1):193-8. PubMed ID: 9202669 [TBL] [Abstract][Full Text] [Related]
42. Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes. Mamounas M; Leavitt M; Yu M; Wong-Staal F Gene Ther; 1995 Aug; 2(6):429-32. PubMed ID: 7584119 [TBL] [Abstract][Full Text] [Related]
43. High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H. Zhang X; De Alwis M; Hart SL; Fitzke FW; Inglis SC; Boursnell ME; Levinsky RJ; Kinnon C; Ali RR; Thrasher AJ Hum Gene Ther; 1999 Oct; 10(15):2527-37. PubMed ID: 10543617 [TBL] [Abstract][Full Text] [Related]
44. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV. Nathwani AC; Hanawa H; Vandergriff J; Kelly P; Vanin EF; Nienhuis AW Gene Ther; 2000 Feb; 7(3):183-95. PubMed ID: 10694794 [TBL] [Abstract][Full Text] [Related]
45. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer]. Cheng J; Leng X; Peng J Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803 [TBL] [Abstract][Full Text] [Related]
46. Using a fed-batch culture strategy to enhance rAAV production in the baculovirus/insect cell system. Liu YK; Yang CJ; Liu CL; Shen CR; Shiau LD J Biosci Bioeng; 2010 Aug; 110(2):187-93. PubMed ID: 20547323 [TBL] [Abstract][Full Text] [Related]
47. Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidase. Thrasher AJ; de Alwis M; Casimir CM; Kinnon C; Page K; Lebkowski J; Segal AW; Levinsky RJ Gene Ther; 1995 Sep; 2(7):481-5. PubMed ID: 7584126 [TBL] [Abstract][Full Text] [Related]
48. Comparative transcriptomic and proteomic kinetic analysis of adeno-associated virus production systems. Lin YC; Lu M; Cai W; Hu WS Appl Microbiol Biotechnol; 2024 Jun; 108(1):385. PubMed ID: 38896252 [TBL] [Abstract][Full Text] [Related]
49. Improving adeno-associated vector yield in high density insect cell cultures. Mena JA; Aucoin MG; Montes J; Chahal PS; Kamen AA J Gene Med; 2010 Feb; 12(2):157-67. PubMed ID: 20101623 [TBL] [Abstract][Full Text] [Related]
50. Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector preps. Brimble MA; Cheng PH; Winston SM; Reeves IL; Souquette A; Spence Y; Zhou J; Wang YD; Morton CL; Valentine M; Thomas PG; Nathwani AC; Gray JT; Davidoff AM Mol Ther Methods Clin Dev; 2022 Mar; 24():280-291. PubMed ID: 35211640 [TBL] [Abstract][Full Text] [Related]
51. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors. Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729 [TBL] [Abstract][Full Text] [Related]
52. Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap. Wustner JT; Arnold S; Lock M; Richardson JC; Himes VB; Kurtzman G; Peluso RW Mol Ther; 2002 Oct; 6(4):510-8. PubMed ID: 12377193 [TBL] [Abstract][Full Text] [Related]
53. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector. Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450 [TBL] [Abstract][Full Text] [Related]
54. [A novel packaging system of recombinant AAV5/5 vector]. Dong X; Tian W; Yuan Z; Tan S; Wu X Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):679-86. PubMed ID: 20684314 [TBL] [Abstract][Full Text] [Related]
55. Cell lines for the production of recombinant adeno-associated virus. Clark KR; Voulgaropoulou F; Fraley DM; Johnson PR Hum Gene Ther; 1995 Oct; 6(10):1329-41. PubMed ID: 8590738 [TBL] [Abstract][Full Text] [Related]
56. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations. Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197 [TBL] [Abstract][Full Text] [Related]
57. Expression of human nerve growth factor beta gene in central nervous system mediated by recombinant adeno-associated viruses type-2 vector. Gao K; Wu YJ; Wu XB; Rao CM; Wang JZ Chin Med J (Engl); 2004 Sep; 117(9):1370-6. PubMed ID: 15377431 [TBL] [Abstract][Full Text] [Related]
58. Bioreactor production of recombinant herpes simplex virus vectors. Knop DR; Harrell H Biotechnol Prog; 2007; 23(3):715-21. PubMed ID: 17461549 [TBL] [Abstract][Full Text] [Related]
59. Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies. Clément N; Knop DR; Byrne BJ Hum Gene Ther; 2009 Aug; 20(8):796-806. PubMed ID: 19569968 [TBL] [Abstract][Full Text] [Related]